Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) Cancers

NCT00231855 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Neoplasms
Uterine Neoplasms

Interventions

DRUG: Topotecan and Taxotere

Sponsor

Montefiore Medical Center

Collaborators

[object Object]
[object Object]